These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
991 related items for PubMed ID: 15352606
1. Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies. Pirotte B, Goldman S, Massager N, David P, Wikler D, Lipszyc M, Salmon I, Brotchi J, Levivier M. J Neurosurg; 2004 Sep; 101(3):476-83. PubMed ID: 15352606 [Abstract] [Full Text] [Related]
2. Stereotactic brain biopsy guided by positron emission tomography (PET) with [F-18]fluorodeoxyglucose and [C-11]methionine. Pirotte B, Goldman S, David P, Wikler D, Damhaut P, Vandesteene A, Salmon L, Brotchi J, Levivier M. Acta Neurochir Suppl; 1997 Sep; 68():133-8. PubMed ID: 9233429 [Abstract] [Full Text] [Related]
3. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. Pirotte B, Goldman S, Massager N, David P, Wikler D, Vandesteene A, Salmon I, Brotchi J, Levivier M. J Nucl Med; 2004 Aug; 45(8):1293-8. PubMed ID: 15299051 [Abstract] [Full Text] [Related]
4. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. Goldman S, Levivier M, Pirotte B, Brucher JM, Wikler D, Damhaut P, Dethy S, Brotchi J, Hildebrand J. J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808 [Abstract] [Full Text] [Related]
5. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas. Borbély K, Nyáry I, Tóth M, Ericson K, Gulyás B. J Neurol Sci; 2006 Jul 15; 246(1-2):85-94. PubMed ID: 16603193 [Abstract] [Full Text] [Related]
11. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? Tsuyuguchi N, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Takami T, Otsuka Y, Sakamoto S, Ohata K, Goto T, Hara M. J Neurosurg; 2003 May 15; 98(5):1056-64. PubMed ID: 12744366 [Abstract] [Full Text] [Related]
12. Combined magnetic resonance imaging- and positron emission tomography-guided stereotactic biopsy in brainstem mass lesions: diagnostic yield in a series of 30 patients. Massager N, David P, Goldman S, Pirotte B, Wikler D, Salmon I, Nagy N, Brotchi J, Levivier M. J Neurosurg; 2000 Dec 15; 93(6):951-7. PubMed ID: 11117867 [Abstract] [Full Text] [Related]
14. Comparison of F-18 FDG and C-11 methionine PET/CT for the evaluation of recurrent primary brain tumors. Tripathi M, Sharma R, Varshney R, Jaimini A, Jain J, Souza MM, Bal J, Pandey S, Kumar N, Mishra AK, Mondal A. Clin Nucl Med; 2012 Feb 15; 37(2):158-63. PubMed ID: 22228339 [Abstract] [Full Text] [Related]
17. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging]. Cai L, Gao S, Li DC, Li YS, Chen QS, Xing XL. Zhonghua Zhong Liu Za Zhi; 2009 Feb 15; 31(2):134-8. PubMed ID: 19538892 [Abstract] [Full Text] [Related]
19. Results of positron emission tomography guidance and reassessment of the utility of and indications for stereotactic biopsy in children with infiltrative brainstem tumors. Pirotte BJ, Lubansu A, Massager N, Wikler D, Goldman S, Levivier M. J Neurosurg; 2007 Nov 15; 107(5 Suppl):392-9. PubMed ID: 18459902 [Abstract] [Full Text] [Related]